1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Data Triangulation and Validation
4. North America Liposome Drug Delivery Market Landscape
4.1 Overview
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain
5. North America Liposome Drug Delivery Market – Key Market Dynamics
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints
6. North America Liposome Drug Delivery Market Regional Analysis
6.2 North America Liposome Drug Delivery Market Revenue 2017-2027 (US$ Million)
6.3 North America Liposome Drug Delivery Market Forecast Analysis
7. North America Liposome Drug Delivery Market Analysis – by Product type
7.1 Liposomal Doxurubicin
- 7.1.1 Overview
- 7.1.2 Liposomal Doxurubicin: North America Liposome Drug Delivery Market – Revenue and Forecast, 2017-2027 (US$ Million)
7.2 Liposomal Paclitxel
- 7.2.1 Overview
- 7.2.2 Liposomal Paclitxel: North America Liposome Drug Delivery Market – Revenue and Forecast, 2017-2027 (US$ Million)
7.3 Liposomal Amphotericin B
- 7.3.1 Overview
- 7.3.2 Liposomal Amphotericin B: North America Liposome Drug Delivery Market – Revenue and Forecast, 2017-2027 (US$ Million)
8. North America Liposome Drug Delivery Market Analysis – by Technology
8.1 Stealth Liposome Technology
- 8.1.1 Overview
- 8.1.2 Stealth Liposome Technology: North America Liposome Drug Delivery Market – Revenue and Forecast, 2017-2027 (US$ Million)
8.2 Non PEGylated Liposome Technology
- 8.2.1 Overview
- 8.2.2 Non PEGylated Liposome Technology: North America Liposome Drug Delivery Market – Revenue and Forecast, 2017-2027 (US$ Million)
8.3 Depofoam Liposome technology
- 8.3.1 Overview
- 8.3.2 Depofoam Liposome technology: North America Liposome Drug Delivery Market – Revenue and Forecast, 2017-2027 (US$ Million)
8.4 Lysolipid thermally Sensitive Liposome Technology
- 8.4.1 Overview
- 8.4.2 Lysolipid thermally Sensitive Liposome Technology: North America Liposome Drug Delivery Market – Revenue and Forecast, 2017-2027 (US$ Million)
9. North America Liposome Drug Delivery Market Analysis – by Application
9.1 Fungal Diseases
- 9.1.1 Overview
- 9.1.2 Fungal Diseases: North America Liposome Drug Delivery Market – Revenue and Forecast, 2017-2027 (US$ Million)
9.2 Cancer Therapy
- 9.2.1 Overview
- 9.2.2 Cancer Therapy: North America Liposome Drug Delivery Market – Revenue and Forecast, 2017-2027 (US$ Million)
9.3 Pain management
- 9.3.1 Overview
- 9.3.2 Pain management: North America Liposome Drug Delivery Market – Revenue and Forecast, 2017-2027 (US$ Million)
9.4 Viral Vaccine
- 9.4.1 Overview
- 9.4.2 Viral Vaccine: North America Liposome Drug Delivery Market – Revenue and Forecast, 2017-2027 (US$ Million)
10. North America Liposome Drug Delivery Market – North America Analysis
10.1 Overview
10.2 North America
- 10.2.1 North America Liposome Drug Delivery Market Breakdown, by Key
Country, 2020 and 2027 (%)
- 10.2.1.1 North America Liposome Drug Delivery Market – Revenue and
Forecast Analysis – by Country
- 10.2.1.1 US:
North America Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
- 10.2.1.1.1 US: North America Liposome Drug Delivery Market Breakdown, by Product type
- 10.2.1.1.2 US: North America Liposome Drug Delivery Market Breakdown, by Technology
- 10.2.1.1.3 US: North America Liposome Drug Delivery Market Breakdown, by Application
- 10.2.1.2 Canada:
North America Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
- 10.2.1.2.1 Canada: North America Liposome Drug Delivery Market Breakdown, by Product type
- 10.2.1.2.2 Canada: North America Liposome Drug Delivery Market Breakdown, by Technology
- 10.2.1.2.3 Canada: North America Liposome Drug Delivery Market Breakdown, by Application
- 10.2.1.3 Mexico :
North America Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
- 10.2.1.3.1 Mexico : North America Liposome Drug Delivery Market Breakdown, by Product type
- 10.2.1.3.2 Mexico : North America Liposome Drug Delivery Market Breakdown, by Technology
- 10.2.1.3.3 Mexico : North America Liposome Drug Delivery Market Breakdown, by Application
11. Competitive Landscape
11.1 Heat Map Analysis
11.2 Company Positioning and Concentration
12. Industry Landscape
12.1 Overview
12.2 Market Initiative
12.3 Partnerships and Collaborations
12.4 Other Developments
13. Company Profiles
13.1 Takeda pharmaceutical company
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 Novartis AG
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 Ipsen pharma
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 Celsion Inc
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 Luye pharma group
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
14. Appendix
14.1 About Business Market Insights
14.2 List of Abbreviations
Get Free Sample For North America Liposome Drug Delivery Market
